Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.

News | January 25, 2012
January 25, 2012 — Terumo Cardiovascular Systems entered into an exclusive agreement with LAAx Inc. to distribute the...
News | November 18, 2011
November 18, 2011 – Boston Scientific’s Watchman left atrial appendage (LAA) closure device has been implanted in the...
Feature | August 25, 2011
August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro...
News | May 23, 2011
May 23, 2011 -- Boston Scientific Corporation announced results from a clinical study evaluating the use of its...
News | May 18, 2011
May 18, 2011 - Jasbir Sra, M.D., and Tanvir Bajwa, M.D., are the first in Wisconsin to implant a new device in a...
News | March 07, 2011
March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent...
News | March 04, 2011
Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a...
Feature | February 17, 2011 | Dave Fornell
Based on my observations and the devices that caught the eye of the doctors on the Diagnostic & Interventional...
News | January 19, 2011
Continuing to build a portfolio of transcatheter structural heart technology, Boston Scientific today signed a...
Feature | December 06, 2010 | Dave Fornell
Transcatheter valve replacement, especially transcatheter aortic valve implantation (TAVI), took center stage at the...
News | November 03, 2010
November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure...
News | October 29, 2010
The first-in-man use of the Coherex WaveCrest left atrial appendage (LAA) occluder system was successfully performed...
Feature | October 18, 2010
St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will...
News | October 04, 2010
October 4, 2010 – Germany will reimburse patients who have a left atrial appendage closure procedure in 2011. The...

The Watchman device is a transcatheter left atrial appendage occluder. It is meant to be an alternative to blood thinners in preventing stroke in patients with atrial fibrillation.

Feature | September 07, 2010 | John Kao, M.D., FACC and Anupama Shivaraju, M.D.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major risk factor for developing...